Crohn’s - Pamela Smith, MD, MS (2021 Conference) (LDN, low dose naltrexone)

Dr. Pamela Smith discusses Crohn’s, an autoimmune disease, from both a conventional and personalized medicine approach. Siting research and her own clinical experience, Dr. Smith discusses traditional and complementary treatment, dietary and nutritional therapies, as well as the use of Low Dose Naltrexone in treating Crohn’s Disease.

Cooling the fire of lichen planopilaris - Apple Bodemer, MD (2021 Conference) (LDN, low dose naltrexone)

Autoimmunity in Families - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

A Non-Invasive First Approach Toward Idiopathic Female Infertility - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

An Integrative Approach to Sarcoidosis and Mixed Connective Tissue Disease - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)

Microbiome Medicine: Clinical Correlations From The Trenches - Sarah Zielsdorf, MD, MS (2021 Conference) (LDN, low dose naltrexone)

In her presentation, Dr. Zielsdorf shares the importance and complexity of the human microbiome and best practices (from her own clinical experience) for restoring the gut microbiome and intestinal barrier.

Nuts and Bolts of The Thyroid Gland: Therapeutic Targets by Sarah Zielsdorf, MD (2021 Conference) (LDN, low dose naltrexone)

Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

NutriChem's LDN Book Event with Dr. Yousuf Siddiqui (Low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Yousuf Siddiqui, B.Arch.Sci., N.D

Autoimmunity, The Thyroid, Low-dose Naltrexone (LDN) & Beyond

Pharmacist Kent MacLeod at the LDN Book Event 2020 (Low dose naltrexone) from LDN Research Trust on Vimeo.

Kent MacLeod, RPh., B.Sc., Owner & CEO of NutriChem Compounding Pharmacy & Clinic

Low-dose Naltrexone (LDN) & The Gut Microbiome